Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT01889095
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Registry
-
NCT01889095
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Iran
- Registry status
- Completed
Technical summary
Registry record NCT01889095. Randomized; single masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2011-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients
- Condition
- Diabetes Type 2
- Intervention (Drug)
- BIAsp 30
- Intervention (Drug)
- NPH/Reg
- Lead sponsor
- Tehran University of Medical Sciences
Record details
- Record id
cardio:ct-nct01889095- Content hash
76203508cfb87ea3955988d1bdc75bfe74751d7d8766dd6e83d5283bff221512